These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2765023)

  • 1. Malignant melanoma and redheads.
    Clayson DE
    West J Med; 1989 Jan; 150(1):91-2. PubMed ID: 2765023
    [No Abstract]   [Full Text] [Related]  

  • 2. A case-control study of malignant melanoma in Israeli kibbutzim.
    Tabenkin H; Tamir A; Sperber AD; Shapira M; Shvartzman P
    Isr Med Assoc J; 1999 Nov; 1(3):154-7. PubMed ID: 10731323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-control study to identify melanoma risk factors in the Belgian population: the significance of clinical examination.
    Nijsten T; Leys C; Verbruggen K; Verlinden V; Drieghe J; Stas M; Lambert J; DeGreef H; Garmyn M
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):332-9. PubMed ID: 15857460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Eye and hair pigmentation in malignant melanomas and other malignant skin tumors].
    Brachtel R; Eckes LK
    Hautarzt; 1980 Mar; 31(3):141-4. PubMed ID: 7399903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red hairs, number of nevi, and risk of cutaneous malignant melanoma: results from a case-control study in Italy.
    Naldi L; Randi G; Di Landro A; La Vecchia C
    Arch Dermatol; 2006 Jul; 142(7):935-6. PubMed ID: 16847220
    [No Abstract]   [Full Text] [Related]  

  • 6. Ambient UVB and melanoma risk in the United States: a case-control analysis.
    Lea CS; Scotto JA; Buffler PA; Fine J; Barnhill RL; Berwick M
    Ann Epidemiol; 2007 Jun; 17(6):447-53. PubMed ID: 17395487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
    Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
    Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive interaction between light iris color and ultraviolet radiation in relation to the risk of uveal melanoma: a case-control study.
    Schmidt-Pokrzywniak A; Jöckel KH; Bornfeld N; Sauerwein W; Stang A
    Ophthalmology; 2009 Feb; 116(2):340-8. PubMed ID: 19091418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.
    Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K
    Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occupational physical activity and risk of malignant melanoma: the Western Canada Melanoma Study.
    Lee TK; MacArthur AC; Gallagher RP; Elwood MJ
    Melanoma Res; 2009 Aug; 19(4):260-6. PubMed ID: 19531966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for ocular melanoma: Western Canada Melanoma Study.
    Gallagher RP; Elwood JM; Rootman J; Spinelli JJ; Hill GB; Threlfall WJ; Birdsell JM
    J Natl Cancer Inst; 1985 Apr; 74(4):775-8. PubMed ID: 3857374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypical characteristics, lifestyle, social class and uveal melanoma.
    Stang A; Ahrens W; Anastassiou G; Jöckel KH
    Ophthalmic Epidemiol; 2003 Dec; 10(5):293-302. PubMed ID: 14566630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocortin-1 receptor: loss of function mutations and skin cancer.
    Mumm CD; Draznin M
    Dermatol Online J; 2006 Sep; 12(5):13. PubMed ID: 16962028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The simultaneous assessment of constitutional, behavioral, and environmental factors in the development of large nevi.
    Cockburn M; Hamilton A; Mack T
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):200-6. PubMed ID: 17267390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable photoreactivity of hair melanosomes, eu- and pheomelanins at low concentrations: low melanin a risk factor for UVA damage and melanoma?
    Haywood RM; Lee M; Andrady C
    Photochem Photobiol; 2008; 84(3):572-81. PubMed ID: 18399925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Photobiologic aspects of malignant melanoma (clinical studies)].
    Ettler K
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1987; 30(4):419-25. PubMed ID: 3504602
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for malignant melanoma in an Icelandic population sample.
    Rafnsson V; Hrafnkelsson J; Tulinius H; Sigurgeirsson B; Olafsson JH
    Prev Med; 2004 Aug; 39(2):247-52. PubMed ID: 15226032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of melanocortin-1 receptor gene variants in uveal melanoma patients.
    Metzelaar-Blok JA; ter Huurne JA; Hurks HM; Keunen JE; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):1951-4. PubMed ID: 11481256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redheads, lunatics, and the triple threat.
    Hunton DW
    J Ark Med Soc; 2009 Feb; 105(8):173. PubMed ID: 19248344
    [No Abstract]   [Full Text] [Related]  

  • 20. HLA class II polymorphisms in Spanish melanoma patients: homozygosity for HLA-DQA1 locus can be a potential melanoma risk factor.
    Planelles D; Nagore E; Moret A; Botella-Estrada R; Vila E; Guillén C; Montoro JA
    Br J Dermatol; 2006 Feb; 154(2):261-6. PubMed ID: 16433795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.